BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Drug Product News
BBI Solutions Launches A Fully Validated Human Recombinant Cystatin C Antigen 8/27/2014
TNI BioTech Announces First Shipment Of Lodonal® To The Republic Of Panama And The Republic Of Malawi 8/27/2014
Ipsen (IPN.PA) Announces Second Resupply Of Increlex® (Mecasermin [Rdna Origin] Injection) In The U.S. In 2014 8/26/2014
Eli Lilly and Company (LLY) Release: New Type 2 Diabetes Treatment Jardiance® (empagliflozin) Tablets For Adults Now Available In U.S. Pharmacies 8/26/2014
Fera Pharmaceuticals Announces Launch of Moxatag® Authorized Generic 8/25/2014
Mylan Inc. (MYL) Launches First Generic Klor-Con® Extended-Release Tablets 8/22/2014
Pfizer Inc. (PFE) Release: Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With Hr+, Her2- Advanced Breast Cancer 8/21/2014
Telomere Biosciences LLC Announces: TELO-20 For Dogs, The World's First Telomere-Lengthening Supplement For Dogs, To Promote Healthy Aging And Longevity 8/21/2014
Lannett Company, Inc. (LCI) Comments On Utilization Of Digoxin 8/20/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide 8/19/2014
Mylan Inc. (MYL) Launches Generic Precedex™ Injection - Another Key Product Approval 8/19/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Germany By Hexal 8/18/2014
Fresenius Kabi AG Introduces Acetylcysteine Solution 10% In 4 Ml, 10 Ml And 30 Ml Vials 8/18/2014
National Institute for Clinical Excellence (NICE) And Johnson & Johnson (JNJ) Urged To End Zytiga Fiasco 8/15/2014
Pragma Pharmaceuticals Announces Re-Launch of Moxatag® 8/15/2014
U.S. Panel Says Seniors Should Get Pfizer Inc. (PFE)'s Prevnar 13 8/14/2014
PuraMed BioScience Completes the First Production of MigraPure® Gel 8/14/2014
Merck & Co., Inc. (MRK) Statement Regarding Role Of PNEUMOVAX® 23 (Pneumococcal Vaccine Polyvalent) In Updated ACIP Recommendations For Pneumococcal Vaccination In Adults 8/14/2014
Amneal Pharmaceuticals Announces Four New Generics 8/13/2014
Sanofi US (SNY) Launches Authorized Generic Version Of Eloxatin® (oxaliplatin Injection) 8/12/2014
Sanofi (France) (SAN.PA), PATH Roll Out First Large-Scale Batches Of Antimalarial Drug 8/12/2014
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche (RHHBY)'s New $152,850 Breast Cancer Drug 8/11/2014
Mylan Inc. (MYL) Launches Generic Xeloda® Tablets 8/11/2014
Fresenius Kabi AG Release: Diprivan® (Propofol) Injectable Emulsion, USP Now Available In 10 Ml Vials 8/11/2014
BTG plc (BTG.L) Release: First Varicose Vein Patient Treated With FDA-Approved Varithena® (polidocanol Injectable Foam) 1% 8/11/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, loxapine) In Guatemala 8/8/2014
NextSource Biotechnology Gains FDA Approval For Use Of Tradename Gleostine™ (Lomustine), An Anti-Cancer Chemotherapy Agent 8/8/2014
Suneva Medical's Regenica® Skin Care System Gets New Look 8/8/2014
A Little Drug From Questcor Pharmaceuticals, Inc. (QCOR) Generates Controversy And A $220 Million Medicare Bill 8/7/2014
Merck & Co., Inc. (MRK) Concerned For Diabetes Patients In Canada As Top Drugs Are Cut From Program 8/6/2014
Sagent Pharmaceuticals, Inc. Announces The Reintroduction Of Irinotecan Hydrochloride Injection, USP 8/5/2014
Cubist Pharmaceuticals, Inc. (CBST)’s Once-Daily SIVEXTRO™ (Tedizolid Phosphate) Available For Physician And Hospital Order In I.V. And Oral Formulations 8/5/2014
bioCSL Inc. Launches AFLURIA® Shipping Campaign For 2014-2015 Seasonal Influenza 8/5/2014
Gilead Sciences, Inc. (GILD) Battles To Shift Debate Over $1,000 Hepatitis Pills From Costs To Cures 8/5/2014
Troubled GlaxoSmithKline (GSK) Gets A Lift As Express Scripts Inc. Reinstates Lung Drug Advair 8/5/2014
Blow To Amgen (AMGN)'s Profits As Express Scripts Inc. Drops Drugs From List Of Preferred Drugs 8/4/2014
Tekmira Pharmaceuticals Corporation (TKMR) Says Ebola Drug Not Used To Treat U.S. Aid Workers 8/4/2014
Eli Lilly and Company (LLY) Release: Type 2 Diabetes: Jentadueto® (linagliptin and metformin hydrochloride) Tablets Label Updated To Include New Data On Blood Glucose Reductions In Treatment-Naive Adults With High Baseline A1C 8/4/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Sweden By Sandoz, Inc. 8/4/2014
Certara Corporation Launches D360 In Japan To Improve Drug Discovery And Development Productivity 8/4/2014
Chiesi Farmaceutici SpA And uniQure Provide Update On Glybera® Launch 8/4/2014
PuraMed BioScience Rebrands Its Natural Migraine Relief Medication, Lipigesic M 7/31/2014
BioPharm Executive: Have Drugs Finally Been Priced Too High? 7/31/2014
GlaxoSmithKline (GSK)'s Tanzeum™ Is Now Available In Pharmacies In The U.S. 7/30/2014
INNOPHARMA Announces Launch Of Olanzapine For Injection, 10mg/Vial In Canada 7/30/2014
AstraZeneca PLC (AZN) Fights With Pediatrician Group Over Preemie Drug Guidelines 7/29/2014
Akrimax Pharmaceuticals Initiates CONTROL Patient Registry For Tirosint® (Levothyroxine Sodium) Capsules 7/29/2014
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 7/28/2014
The Upsher-Smith Laboratories Galaxy™ Portfolio Of Antiepileptic Drugs Now Available 7/28/2014
Boehringer Ingelheim Corporation Release: Benefits And Safety Of Pradaxa® (Dabigatran Etexilate Mesylate) Repeatedly Confirmed 7/24/2014
Abbott Introduces New Similac® Breastfeeding Supplement With DHA, Lutein And Vitamin E 7/24/2014
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States 7/24/2014
Daiichi Sankyo, Inc. (4568.t) And Eli Lilly and Company (LLY): Heart Patients In England And Wales Offered More Choice Of Therapies As National Institute for Clinical Excellence (NICE) Extends Recommendations For Prasugrel 7/23/2014
Third Product In Vernalis PLC (VNLPY.PK)’ Cough Cold Pipeline (CCP-08) Achieves Proof-Of-Concept 7/22/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014
Sanofi Pasteur (SASY.PA) Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States 7/22/2014
Shire Release: Firazyr®: First Subcutaneous Treatment For Acute Attacks Of Rare And Serious Swelling Disorder Now Available In Canada 7/21/2014
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
Durata Therapeutics, Inc.  (DRTX) Announces The U.S. Launch Of Dalvance™ 7/18/2014
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Canada 7/17/2014
NovaBay Pharmaceuticals, Inc. (NBY) Announces Direct US Marketing-Sales Campaign For New i-Lid™ Cleanser Product 7/16/2014
Celsion Corporation (CLN) Announces Commercialization Of Reagent Products 7/15/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
Upsher-Smith Laboratories Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules 7/14/2014
BioTie Therapies Corp.: Selincro Receives Positive Draft Guidance From UK's National Institute for Clinical Excellence (NICE) 7/10/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
The International Myeloma Foundation Says IMNOVID® (Pomalidomide), The Newest Medication For Advanced Cases Of Multiple Myeloma, Is Approved For Reimbursement In Sweden, Spain, And Switzerland 7/10/2014
Kaleo Release: EVZIO™ (naloxone HCl injection) Auto-Injector Now Available In The United States For The Emergency Treatment Of Opioid Overdose 7/10/2014
Par Pharmaceutical, Inc. Begins Shipment Of Fluphenazine Decanoate Injection, USP 7/9/2014
Insight Pharmaceuticals Release: MONISTAT® Announces New Suite Of Complete Care™ Products 7/9/2014
PTC Therapeutics, Inc. (PTCT) Announces Expanded Access Program For Translarna™ (ataluren) 7/9/2014
Mylan Inc. (MYL) Launches Generic Micardis® Tablets 7/8/2014
Perrigo Company (PRGO) Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg 7/8/2014
Skystar Bio-Pharmaceutical (CGPN) Launches Bovine Immunoglobulin G (IgG) Kits In China 7/8/2014
Novartis AG (NVS) Unveils Stronger Drug In Bid To Boost Malaria Treatment 7/7/2014
Tianyin Pharmaceutical Co, Inc. Receives GMP For Tablets Formulation In Early July 7/7/2014
Novartis AG (NVS) Begins Shipment Of Seasonal Influenza Vaccines To US Market For The 2014-2015 Season 7/3/2014
Upsher-Smith Laboratories Announces Launch Of The First And Only Generic Transdermal Testosterone Gel Available In Three Convenient Configurations 7/2/2014
Upsher-Smith Laboratories Launches Qudexy™ XR (Topiramate) Extended-Release Capsules For Treatment Of Specific Seizure Types 6/30/2014
Aqua Pharmaceuticals Announces Launch Of Cordran® Ointment (Flurandrenolide Ointment, USP) 0.05% 6/30/2014
NPS Pharmaceuticals, Inc. (NPSP) Release: FDA Approves Updated Labeling For Gattex® (Teduglutide [RDNA Origin]) For Injection To Include Long-Term Data 6/30/2014
Ohm Laboratories, Inc. To Launch Valsartan Tablets 6/27/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Duloxetine Delayed-Release Capsules USP 6/27/2014
Quest Products, Inc. Introduces New ProVent® Eczema And Psoriasis Spray® 6/25/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Paricalcitol Capsules 6/25/2014
Hetero Launches Darbepoetin Alfa, A Much Needed Biosimilar Anemia Treatment In India 6/19/2014
Manzo Pharmaceuticals Announces The Release Of Its Newest Product Tummy Relief A Natural Colic Remedy For Babies 6/18/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: AMITIZA® (Lubiprostone) Receives National Institute for Clinical Excellence (NICE) Recommendation 6/18/2014
DermWorx Incorporated / LETI Laboratories S.L. To Launch Leading Atopic Skincare Line To The U.S. Market 6/17/2014
UK's Cost Agency Not Ready To Back Gilead Sciences, Inc. (GILD)'s Controversial Hepatitis C Drug 6/17/2014
Cepheid (CPHD) Announces European Release Of Xpert Carba-R, A Molecular Test For Rapid And Accurate Detection Of Carbapenemase-Producing Gram-Negative Bacteria 6/16/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In The United Kingdom 6/16/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: ENTYVIO™ (vedolizumab) Now Available In The United States For The Treatment Of Adults With Moderately To Severely Active Ulcerative Colitis And Crohn's Disease 6/16/2014
Italy To Fund Unapproved Use Of Roche (RHHBY) Drug To Cut Costs; Move Startles The Industry 6/13/2014
MediGene AG (MDGEF.PK) Announces Market Launch Of Veregen®: In Belgium, Denmark And Finland 6/12/2014
Forest Laboratories, Inc. (FRX) Announces Intention To Continue Marketing Both NAMENDA® TABLETS And Once-Daily NAMENDA XR® Into The Fall Of 2014 6/11/2014
Auxilium Pharmaceuticals (AUXL) Announces Launch Of Authorized Generic Version Of Testim (Testosterone Gel) 6/11/2014
Mylan Inc. (MYL) Launches Generic Actonel® Tablets, 150 mg 6/11/2014
Medivir AB (MVRBF) Release: OLYSIO™ Available Soon In All Nordic Countries For The Treatment Of Adults With Hepatitis C Genotype 1 And 4 Infection 6/10/2014
Mylan Inc. (MYL) Launches Generic Paraplatin® Injection 6/9/2014
Both Are Roche (RHHBY)'s Drugs, But Which One Could Save The U.S. $3 Billion? 6/5/2014
Norgen Biotek Corporation Launches 6 Novel Kits For The Isolation Of High-Quality Circulating Nucleic Acids From Blood, Plasma, Serum And Urine 6/4/2014
CorePharma LLC Announces The Launch Of Dextroamphetamine Sulfate Tablets, USP 6/4/2014
Paragon BioTeck Announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available 6/4/2014
Gilead Sciences Canada, Inc. (GILD) Release: Quebec Becomes First Province To Reimburse Sovaldi® For The Treatment Of Chronic Hepatitis C 6/3/2014
H2-Pharma Launches Authorized Generic LIPOFEN 6/3/2014
Mission Pharmacal Company Begins Exclusive Promotion Of Elestrin® (Estradiol Gel) 0.06% In The U.S. Market 5/30/2014
Mylan Inc. (MYL) Launches Generic Malarone® Tablets 5/29/2014
Genzyme Corporation (GENZ)'s Lemtrada Recommended For Reimbursement On NHS By The National Institute for Clinical Excellence (NICE) 5/28/2014
Polyplus Transfection Launches A New Transfection Reagent For Bioproduction 5/28/2014
ULURU Inc. Announces Shipments Of Altrazeal® To Italy, Spain And Portugal 5/27/2014
Solara Labs Announces The Launch Of BariMelts® 5/27/2014
Pfizer Inc. (PFE) Brings Frequent Heartburn Relief Over-The-Counter With New Nexium® 24HR 5/27/2014
DiscoveRx Corporation Enables Predictive In Vitro Drug Combination Studies With Launch Of Biomap® Combo ELECT 5/21/2014
TOLMAR Pharmaceuticals Established To Market ELIGARD For Advanced Prostate Cancer In The U.S. And Puerto Rico 5/16/2014
ALK-Abello A/S's Partner For North America, Merck & Co., Inc. (MRK), Announces Launch Of RAGWITEK™ In Canada 5/15/2014
Mylan Inc. (MYL) Launches Generic Zyprexa Zydis® Tablets 5/14/2014
Negative National Institute for Clinical Excellence (NICE) Draft Guidance On Janssen Biotech Inc. (JNJ)'s Zytiga For Prostate Cancer 5/14/2014
Ipsen (IPN.PA) Announces A Step Forward In The Resupply Of Increlex® (Mecasermin [rDNA Origin] Injection) In The U.S. 5/13/2014
Veracyte, Inc. (VCYT) Launches Afirma® Malignancy Classifiers To Further Help Thyroid Nodule Patients Avoid Unnecessary Surgeries And Lower Healthcare Costs 5/13/2014
INSYS Therapeutics Issues Clarifying Statement 5/13/2014
Ajanta Pharma Announces The Launch Of Risperidone Tablets 5/9/2014
Actavis (ACT) Launches Generic Version Of Catapres-TTS® 5/8/2014
CorePharma LLC Launches Methylphenidate Hydrochloride Tablets USP 5/8/2014
Cumberland Pharmaceuticals (CPIX) Launches Vaprisol® Promotion 5/7/2014
Greer Labs Launches ORALAIR®, The First And Only Sublingual Allergy Immunotherapy Tablet With A Mix Of Five Grass Allergens For The Treatment Of Grass Pollen Allergy 5/5/2014
Otsuka Pharmaceutical Co., Ltd. Release: New Once-Monthly Treatment For Schizophrenia, ABILIFY MAINTENA™ (Aripiprazole For Prolonged Release Injectable Suspension), Now Available In Canada 5/5/2014
Covance Inc. (CVD) Launches New Brand: Solutions Made Real™ 5/2/2014
Access Pharmaceuticals (ACCP) MuGard Selected For Cover Article In The Print Edition Of The Journal Cancer 5/1/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In The Nordic Countries 5/1/2014
MyoScience Inc. Release: Novel Pain Treatment Is Now Available: Iovera System Harnesses The Power Of Cold To Block Pain 5/1/2014
Gilead Sciences, Inc. (GILD)'s Solvadi Strikes Again: $1,000 A Pill Rattles Medicaid Programs 4/30/2014
Medivir AB (MVRBF) Release: Adasuve Will Now Be Launched In Sweden, Norway, Finland, And Denmark 4/30/2014
GlaxoSmithKline (GSK)/Theravance, Inc. (THRX) Release: Anoro™ Ellipta® Now Available In The U.S. For Treatment Of COPD 4/28/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Fenofibrate Capsules, USP 43 Mg And 130 Mg 4/23/2014
Zogenix, Inc. (ZGNX) Responds To Governor's Action Singling Out Zohydro™ ER In Massachusetts, Encourages Officials To Consider Patient Needs And Effective Class-Wide Measures 4/23/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Initiation Of An Expanded Access Program To Provide Firdapse At No Cost To U.S. Patients With Lambert-Eaton Myasthenic Syndrome 4/23/2014
NovaBay Pharmaceuticals, Inc. (NBY) Introduces Advanced I-Lid Cleanser For Cleaning Eyelids And Skin Around The Eye 4/23/2014
PuriCore Launches NovaZo Wound Hydrogel For Equine And Companion Animals 4/23/2014
Heat On Roche (RHHBY) To Cut Kadcyla Price After National Institute for Clinical Excellence (NICE) Says "No" 4/23/2014
Oculus Innovative Sciences, Inc. (OCLS)' Partner, More Pharma Corporation, Launches Microcyn®-Based Oral And Throat Infection Treatment Product In Mexico 4/22/2014
Sagent Pharmaceuticals, Inc. Announces The Reintroduction Of Adenosine Injection, USP 4/21/2014
Stolen Roche (RHHBY) Cancer Drug Found On Market 4/18/2014
Mylan Inc. (MYL) Launches First Generic ORTHO EVRA® Patch 4/17/2014
Anika Therapeutics (ANIK) Announces First U.S. Commercial Sale Of Monovisc® 4/16/2014
Apricus Biosciences (APRI)' Partner In The United Kingdom Accepts First Shipment Of Vitaros® 4/16/2014
IMPAX Laboratories, Inc. (IPXL) Launches Authorized Generic RENVELA® 4/16/2014
Dr. Reddy's Laboratories Ltd. (RDY)’ Announces The Launch Of Eszopiclone Tablets C-IV 4/16/2014
Ferring Pharmaceuticals Release: UK National Institute for Clinical Excellence (NICE) Guidance Recommends FIRMAGON® (Degarelix) For The Treatment Of Advanced Hormone-Dependent Prostate Cancer Only In People With Spinal Metastases Who Present With Signs Or Symptoms Of Impending Spinal Cord Compression (ISCC) 4/15/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Lunesta® Tablets In The United States 4/15/2014
FDA Extends Market Exclusivity Six Months For BioMarin Pharmaceutical Inc. (BMRN)'s Rare Disease Therapy KUVAN® (Sapropterin Dihydrochloride) Powder For Oral Solution And Tablets 4/14/2014
Doctors Welcome Hepatitis C Drug Rivals, Gilead Sciences, Inc. (GILD) Still Leads 4/11/2014
Vanda Pharmaceuticals, Inc. (VNDA) Announces Availability of HETLIOZ™ (tasimelteon) For Non-24-Hour Sleep-Wake Disorder (Non-24) 4/10/2014
AbbVie (ABBV) Announces Availability Of New Advanced Parkinson's Treatment In Canada 4/10/2014
Ironwood Pharmaceuticals (IRWD) And Forest Laboratories, Inc. (FRX) Launch New Direct-To-Consumer Awareness Campaign For LINZESS® 4/10/2014
Pharmacy Benefit Manager Express Scripts Inc. Enraged, Looks To Force Gilead Sciences, Inc. (GILD) To Cut Price Of Sovaldi 4/9/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Plans To Gradually Phase-Out Of Ranbaxy Laboratories (RANBAXY.BO)-Branded Drugs In U.S. 4/9/2014
Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe 4/7/2014
ULURU Inc. Release: Initial Pharmacoeconomic Data Demonstrates Cost Benefits Of Altrazeal® 4/7/2014
Sunovion Pharmaceuticals Inc. Release: Once-Daily Aptiom® (Eslicarbazepine Acetate) For The Adjunctive Treatment Of Partial-Onset Seizures Now Available In U.S. Pharmacies 4/7/2014
Zogenix, Inc. (ZGNX) Statement: Let's Get The Facts Straight About Zohydro ER 4/3/2014
Aerocrine Release: National Institute for Clinical Excellence (NICE) Recommends The Use Of Exhaled Nitric Oxide (Feno) Testing To Help Diagnose And Manage Asthma 4/2/2014
Swedish Orphan Biovitrum Assumes Direct Responsibility For Orfadin® (Nitisinone) In U.S. And Canada And Introduces Orfadin4U™ 4/1/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Adenosine Injection, USP 3/31/2014
Mission Pharmacal Company Introduces New And Improved Version Of Top-Selling Prescription Prenatal Vitamin, Citranatal Harmony® 3/28/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Amlodipine Besylate And Atorvastatin Calcium Tablets 3/27/2014
Genzyme Corporation (GENZ) Release: U.S. Prescribing Information For Thyrogen Revised To Include Use Of Wider Range Of Radioiodine In Patients 3/27/2014
Sanofi (France) (SAN.PA) Release: National Institute for Clinical Excellence (NICE) Rejects Life-Extending Bowel Cancer Drug Two Weeks After Scottish Approval 3/25/2014
Gilead Sciences, Inc. (GILD)'s $84,000 Treatment Questioned By U.S. Lawmakers 3/25/2014
UK Cancer Drugs Fund Adds Roche (RHHBY), Celgene Corporation (CELG) And Exelixis, Inc. (EXEL) Drugs 3/24/2014
UK Cost Agency Says "No" To Bayer AG (BAYN.DE) Prostate Cancer Drug Xofigo 3/24/2014
Quinnova Pharmaceuticals, Inc. Announces The Launch Of ECOZA™ (Econazole Nitrate) Topical Foam, 1% 3/18/2014
H. Lundbeck A/S (LUN.CO) And Otsuka Pharmaceutical Co., Ltd. Initiate European Launch Of Abilify Maintena® (Aripiprazole), A Once-Monthly Formulation For The Treatment Of Schizophrenia 3/17/2014
NicOx SA (COX.PA) Launches Adenoplus® And Xailin™ Dry Eye Product Range In Europe 3/17/2014
National Institute of Clinical Research Turns Down Celgene (CELG)'s Revlimid 3/17/2014
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania 3/14/2014
FDA Commissioner Defends Zogenix, Inc. (ZGNX)'s Pain Drug As Criticism Intensifies 3/14/2014
Bacterin International, Inc. Announces The Launch Of OsteoSTX, A Novel Biologic Product 3/13/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Receives Notice That Second Indication For AMITIZA For Opioid-Induced Constipation Is Not Approved By Medicines And Healthcare Products Regulatory Agency In U.K. 3/13/2014
Roche (RHHBY) And Jiangsu Province Bring Down High Cost Of Breast Cancer Drug 3/13/2014
Mylan Inc. (MYL) Launches Naloxone Hydrochloride Injection 3/12/2014
Bayer HealthCare (BAY) Launches Eight New Products To Treat Flea And Tick Infestations 3/12/2014
Perrigo Company (PRGO) Announces Launch Of Generic Version Of Neptazane™ (Methazolamide) Tablets 3/12/2014
French Competition Regulator Probes Roche (RHHBY), Novartis AG (NVS) 3/12/2014
Antares Pharma, Inc. (ATRS) Announces LEO Pharma’s Launch Of OTREXUP (Methotrexate) Injection To Dermatologists For Adults With Psoriasis 3/10/2014
Novartis AG (NVS) Muscle Drug Sales May Reach $4 Billion, According To MorphoSys AG 3/7/2014
McNeil Consumer Healthcare Release: The Makers of ZYRTEC® Launch New Dissolve Tabs 3/6/2014
British Watchdog Wants U.S. Biotech Alexion Pharmaceuticals Inc. (ALXN) To Justify Cost Of Drug 3/5/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Moxifloxacin Hydrochloride Tablets 3/5/2014
Citron Research Says Prized Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Drug Missing Key Ingredient 3/4/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches ADASUVE® In U.S. 3/3/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The U.S. Commercial Launch Of ADASUVE® By Teva Pharmaceutical Industries Limited (TEVA) 3/3/2014
Dendreon Corporation (DNDN) Announces Plans To Make PROVENGE® Commercially Available In Europe 3/3/2014
Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs 2/28/2014
Easton Pharmaceuticals (OP: EAPH) Announces The Launching Of Hempstral SA, A New Hemp Based Anti Ageing Product & Reaches Marketing Develop And Distribution Agreement With Hemplifetoday.Com 2/28/2014
Groups Urge FDA To Halt Launch Of Zogenix, Inc. (ZGNX)'s Zohydro Pain Drug 2/28/2014
Cell Therapeutics, Inc. (CTIC) Release: National Institute for Clinical Excellence (NICE) Publishes Final Guidance On PIXUVRI® (pixantrone) 2/27/2014